|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/6886 |
| (11) | Number of the document | 3303619 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16728525.3 |
| Date of filing the European patent application | 2016-05-27 | |
| (97) | Date of publication of the European application | 2018-04-11 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/034856 |
| Date | 2016-05-27 |
| (87) | Number | WO 2016/196381 |
| Date | 2016-12-08 |
| (30) | Number | Date | Country code |
| 201562168668 P | 2015-05-29 | US |
| (72) |
KADEL, Edward, US
KOWANETZ, Marcin, US
WALTER, Kimberly, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | PD-L1 PROMOTER METHYLATION IN CANCER |
| PD-L1 PROMOTER METHYLATION IN CANCER |